MedTrace Logo

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

NCT02602470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2020-04-01

No results posted yet for this study

Summary

To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.

Conditions

  • Rosacea

Interventions

DRUG

Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251)

Azelaic Acid Gel 15%, Azelaic Acid Gel 15% w/Cleanser \& Moisturizing

DRUG

Azelaic Acid Cream

Azelaic Acid Cream 20%

DRUG

Metronidazole gel

Metronidazole Gel 1%, Metronidazole Gel 1% w/ Cleanser, Metronidazole Gel 0.75%, Metronidazole Gel 0.75% w/ Cleanser

DRUG

Metronidazole cream

Metronidazole Cream 1%, Metronidazole Cream 0.75%, Metronidazole Cream 0.75% w/ Cleanser

DRUG

Metronidazole Emulsion

Metronidazole Emulsion 0.75%

DRUG

Metronidazole Lotion

Metronidazole Lotion 0,75%

DRUG

Brimonidine Tartrate Gel

Brimonidine Tartrate Gel 0.33%

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-08
Primary Completion
2016-03-10
Completion
2016-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602470 on ClinicalTrials.gov